<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34376242</PMID><DateCompleted><Year>2022</Year><Month>01</Month><Day>10</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>09</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1750-1326</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Aug</Month><Day>10</Day></PubDate></JournalIssue><Title>Molecular neurodegeneration</Title><ISOAbbreviation>Mol Neurodegener</ISOAbbreviation></Journal><ArticleTitle>SRSF1-dependent inhibition of C9ORF72-repeat RNA nuclear export: genome-wide mechanisms for neuroprotection in amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>53</StartPage><MedlinePgn>53</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">53</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13024-021-00475-y</ELocationID><Abstract><AbstractText Label="BACKGROUND">Loss of motor neurons in amyotrophic lateral sclerosis (ALS) leads to progressive paralysis and death. Dysregulation of thousands of RNA molecules with roles in multiple cellular pathways hinders the identification of ALS-causing alterations over downstream changes secondary to the neurodegenerative process. How many and which of these pathological gene expression changes require therapeutic normalisation remains a fundamental question.</AbstractText><AbstractText Label="METHODS">Here, we investigated genome-wide RNA changes in C9ORF72-ALS patient-derived neurons and Drosophila, as well as upon neuroprotection taking advantage of our gene therapy approach which specifically inhibits the SRSF1-dependent nuclear export of pathological C9ORF72-repeat transcripts. This is a critical study to evaluate (i) the overall safety and efficacy of the partial depletion of SRSF1, a member of a protein family involved itself in gene expression, and (ii) a unique opportunity to identify neuroprotective RNA changes.</AbstractText><AbstractText Label="RESULTS">Our study shows that manipulation of 362 transcripts out of 2257 pathological changes, in addition to inhibiting the nuclear export of repeat transcripts, is sufficient to confer neuroprotection in C9ORF72-ALS patient-derived neurons. In particular, expression of 90 disease-altered transcripts is fully reverted upon neuroprotection leading to the characterisation of a human C9ORF72-ALS disease-modifying gene expression signature. These findings were further investigated in vivo in diseased and neuroprotected Drosophila transcriptomes, highlighting a list of 21 neuroprotective changes conserved with 16&#x2009;human orthologues in patient-derived neurons. We also functionally validated the high neuroprotective potential of one of these disease-modifying transcripts, demonstrating that inhibition of ALS-upregulated human KCNN1-3 (Drosophila SK) voltage-gated potassium channel orthologs mitigates degeneration of human motor neurons and Drosophila motor deficits.</AbstractText><AbstractText Label="CONCLUSIONS">Strikingly, the partial depletion of SRSF1 leads to expression changes in only a small proportion of disease-altered transcripts, indicating that not all RNA alterations need normalization and that the gene therapeutic approach is safe in the above preclinical models as it does not disrupt globally gene expression. The efficacy of this intervention is also validated at genome-wide level with transcripts modulated in the vast majority of biological processes affected in C9ORF72-ALS. Finally, the identification of a characteristic signature with key RNA changes modified in both the disease state and upon neuroprotection also provides potential new therapeutic targets and biomarkers.</AbstractText><CopyrightInformation>&#xa9; 2021. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Castelli</LastName><ForeName>Lydia M</ForeName><Initials>LM</Initials><AffiliationInfo><Affiliation>Sheffield Institute for Translational Neuroscience (SITraN), Department of Neuroscience, University of Sheffield, 385 Glossop Road, Sheffield, S10 2HQ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Cutillo</LastName><ForeName>Luisa</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>School of Mathematics, University of Leeds, Leeds, LS2 9JT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Souza</LastName><ForeName>Cleide Dos Santos</ForeName><Initials>CDS</Initials><AffiliationInfo><Affiliation>Sheffield Institute for Translational Neuroscience (SITraN), Department of Neuroscience, University of Sheffield, 385 Glossop Road, Sheffield, S10 2HQ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sanchez-Martinez</LastName><ForeName>Alvaro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>MRC Mitochondrial Biology Unit, University of Cambridge, Cambridge Biomedical Campus, Hills Road, Cambridge, CB2 0XY, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Granata</LastName><ForeName>Ilaria</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>National Research Council of Italy, High Performance Computing and Networking Institute (ICAR-CNR), 111 Via Pietro Castellino, 80131, Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Ya-Hui</ForeName><Initials>YH</Initials><AffiliationInfo><Affiliation>Sheffield Institute for Translational Neuroscience (SITraN), Department of Neuroscience, University of Sheffield, 385 Glossop Road, Sheffield, S10 2HQ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Myszczynska</LastName><ForeName>Monika A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Sheffield Institute for Translational Neuroscience (SITraN), Department of Neuroscience, University of Sheffield, 385 Glossop Road, Sheffield, S10 2HQ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heath</LastName><ForeName>Paul R</ForeName><Initials>PR</Initials><AffiliationInfo><Affiliation>Sheffield Institute for Translational Neuroscience (SITraN), Department of Neuroscience, University of Sheffield, 385 Glossop Road, Sheffield, S10 2HQ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Livesey</LastName><ForeName>Matthew R</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Sheffield Institute for Translational Neuroscience (SITraN), Department of Neuroscience, University of Sheffield, 385 Glossop Road, Sheffield, S10 2HQ, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuroscience Institute, University of Sheffield, Western Bank, Sheffield, S10 2TN, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ning</LastName><ForeName>Ke</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Sheffield Institute for Translational Neuroscience (SITraN), Department of Neuroscience, University of Sheffield, 385 Glossop Road, Sheffield, S10 2HQ, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuroscience Institute, University of Sheffield, Western Bank, Sheffield, S10 2TN, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Azzouz</LastName><ForeName>Mimoun</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Sheffield Institute for Translational Neuroscience (SITraN), Department of Neuroscience, University of Sheffield, 385 Glossop Road, Sheffield, S10 2HQ, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuroscience Institute, University of Sheffield, Western Bank, Sheffield, S10 2TN, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shaw</LastName><ForeName>Pamela J</ForeName><Initials>PJ</Initials><AffiliationInfo><Affiliation>Sheffield Institute for Translational Neuroscience (SITraN), Department of Neuroscience, University of Sheffield, 385 Glossop Road, Sheffield, S10 2HQ, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuroscience Institute, University of Sheffield, Western Bank, Sheffield, S10 2TN, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guarracino</LastName><ForeName>Mario R</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>National Research Council of Italy, High Performance Computing and Networking Institute (ICAR-CNR), 111 Via Pietro Castellino, 80131, Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Whitworth</LastName><ForeName>Alexander J</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>MRC Mitochondrial Biology Unit, University of Cambridge, Cambridge Biomedical Campus, Hills Road, Cambridge, CB2 0XY, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferraiuolo</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Sheffield Institute for Translational Neuroscience (SITraN), Department of Neuroscience, University of Sheffield, 385 Glossop Road, Sheffield, S10 2HQ, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuroscience Institute, University of Sheffield, Western Bank, Sheffield, S10 2TN, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Milo</LastName><ForeName>Marta</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biomedical Science, University of Sheffield, Western Bank, Sheffield, S10 2TN, UK. marta.milo@astrazeneca.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Present Address: AstraZeneca, Academy House, 136 Hills Road, Cambridge, CB2 8PA, UK. marta.milo@astrazeneca.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hautbergue</LastName><ForeName>Guillaume M</ForeName><Initials>GM</Initials><Identifier Source="ORCID">0000-0002-1621-261X</Identifier><AffiliationInfo><Affiliation>Sheffield Institute for Translational Neuroscience (SITraN), Department of Neuroscience, University of Sheffield, 385 Glossop Road, Sheffield, S10 2HQ, UK. g.hautbergue@sheffield.ac.uk.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuroscience Institute, University of Sheffield, Western Bank, Sheffield, S10 2TN, UK. g.hautbergue@sheffield.ac.uk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>BB/S005277/1</GrantID><Acronym>BB_</Acronym><Agency>Biotechnology and Biological Sciences Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/R024162/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>129016</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/S004920/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/M010864/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>HAUTBERGUE/APR16/846-791</GrantID><Acronym>MNDA_</Acronym><Agency>Motor Neurone Disease Association</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>NF-SI-0617-10077</GrantID><Acronym>DH_</Acronym><Agency>Department of Health</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MC_UU_00015/6</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>IS-BRC-1215-20017</GrantID><Acronym>DH_</Acronym><Agency>Department of Health</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>TURNER/OCT15/972-797</GrantID><Acronym>MNDA_</Acronym><Agency>Motor Neurone Disease Association</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/V030140/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>08</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Mol Neurodegener</MedlineTA><NlmUniqueID>101266600</NlmUniqueID><ISSNLinking>1750-1326</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000073885">C9orf72 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000595779">SRSF1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>170974-22-8</RegistryNumber><NameOfSubstance UI="D000068103">Serine-Arginine Splicing Factors</NameOfSubstance></Chemical><Chemical><RegistryNumber>63231-63-0</RegistryNumber><NameOfSubstance UI="D012313">RNA</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D021581" MajorTopicYN="N">Active Transport, Cell Nucleus</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073885" MajorTopicYN="N">C9orf72 Protein</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004330" MajorTopicYN="N">Drosophila</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000066829" MajorTopicYN="N">Neuroprotection</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012313" MajorTopicYN="N">RNA</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000068103" MajorTopicYN="N">Serine-Arginine Splicing Factors</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">C9ORF72-repeat expansions</Keyword><Keyword MajorTopicYN="N">Disease-modifying gene expression signature</Keyword><Keyword MajorTopicYN="N">Genome-wide mechanisms of neuroprotection</Keyword><Keyword MajorTopicYN="N">Pre-clinical models</Keyword><Keyword MajorTopicYN="N">SRSF1-dependent RNA nuclear export</Keyword><Keyword MajorTopicYN="N">Transcriptome</Keyword><Keyword MajorTopicYN="N">Voltage-gated potassium ion channel</Keyword></KeywordList><CoiStatement>GMH, MA, AJW and PJS have patents granted in the USA (US10/801027) and in Europe (EP3430143) for the use of inhibitors of SRSF1 to treat neurodegenerative disorders (WO2017207979A1). The authors declare no other relationships, conditions or circumstances that present a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>3</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>7</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>8</Month><Day>11</Day><Hour>5</Hour><Minute>37</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>8</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>1</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34376242</ArticleId><ArticleId IdType="pmc">PMC8353793</ArticleId><ArticleId IdType="doi">10.1186/s13024-021-00475-y</ArticleId><ArticleId IdType="pii">10.1186/s13024-021-00475-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ, Nicholson AM, Finch NCA, Flynn H, Adamson J, Kouri N, Wojtas A, Sengdy P, Hsiung GYR, Karydas A, Seeley WW, Josephs KA, Coppola G, Geschwind DH, Wszolek ZK, Feldman H, Knopman DS, Petersen RC, Miller BL, Dickson DW, Boylan KB, Graff-Radford NR, Rademakers R. Expanded GGGGCC Hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron. 2011;72(2):245&#x2013;256. doi: 10.1016/j.neuron.2011.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.011</ArticleId><ArticleId IdType="pmc">PMC3202986</ArticleId><ArticleId IdType="pubmed">21944778</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton AE, Majounie E, Waite A, Sim&#xf3;n-S&#xe1;nchez J, Rollinson S, Gibbs JR, Schymick JC, Laaksovirta H, van Swieten J, Myllykangas L, Kalimo H, Paetau A, Abramzon Y, Remes AM, Kaganovich A, Scholz SW, Duckworth J, Ding J, Harmer DW, Hernandez DG, Johnson JO, Mok K, Ryten M, Trabzuni D, Guerreiro RJ, Orrell RW, Neal J, Murray A, Pearson J, Jansen IE, Sondervan D, Seelaar H, Blake D, Young K, Halliwell N, Callister JB, Toulson G, Richardson A, Gerhard A, Snowden J, Mann D, Neary D, Nalls MA, Peuralinna T, Jansson L, Isoviita VM, Kaivorinne AL, H&#xf6;ltt&#xe4;-Vuori M, Ikonen E, Sulkava R, Benatar M, Wuu J, Chi&#xf2; A, Restagno G, Borghero G, Sabatelli M, ITALSGEN Consortium. Heckerman D, Rogaeva E, Zinman L, Rothstein JD, Sendtner M, Drepper C, Eichler EE, Alkan C, Abdullaev Z, Pack SD, Dutra A, Pak E, Hardy J, Singleton A, Williams NM, Heutink P, Pickering-Brown S, Morris HR, Tienari PJ, Traynor BJ. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron. 2011;72(2):257&#x2013;268. doi: 10.1016/j.neuron.2011.09.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.010</ArticleId><ArticleId IdType="pmc">PMC3200438</ArticleId><ArticleId IdType="pubmed">21944779</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown RH, Al-Chalabi A. Amyotrophic lateral sclerosis. N Engl J Med. 2017;377(2):162&#x2013;172. doi: 10.1056/NEJMra1603471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1603471</ArticleId><ArticleId IdType="pubmed">28700839</ArticleId></ArticleIdList></Reference><Reference><Citation>van Es MDMA, MD POH, MD PAC, MD PAA-C, PhD PRJP, MD PJHV, et al. Amyotrophic lateral sclerosis. Lancet. 2017;390(10107):2084&#x2013;2098. doi: 10.1016/S0140-6736(17)31287-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(17)31287-4</ArticleId><ArticleId IdType="pubmed">28552366</ArticleId></ArticleIdList></Reference><Reference><Citation>Olszewska DA, Lonergan R, Fallon EM, Lynch T. Genetics of frontotemporal dementia. Curr Neurol Neurosci Rep. 2016;16(12):107. doi: 10.1007/s11910-016-0707-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11910-016-0707-9</ArticleId><ArticleId IdType="pubmed">27878525</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferraiuolo L, Kirby J, Grierson AJ, Sendtner M, Shaw PJ. Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis. Nat Rev Neurol. 2011;7(11):616&#x2013;630. doi: 10.1038/nrneurol.2011.152.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2011.152</ArticleId><ArticleId IdType="pubmed">22051914</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper-Knock J, Kirby J, Ferraiuolo L, Heath PR, Rattray M, Shaw PJ. Gene expression profiling in human neurodegenerative disease. Nat Rev Neurol. 2012;8(9):518&#x2013;530. doi: 10.1038/nrneurol.2012.156.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2012.156</ArticleId><ArticleId IdType="pubmed">22890216</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper-Knock J, Bury JJ, Heath PR, Wyles M, Higginbottom A, Gelsthorpe C, Highley JR, Hautbergue G, Rattray M, Kirby J, Shaw PJ. C9ORF72 GGGGCC expanded repeats produce splicing dysregulation which correlates with disease severity in amyotrophic lateral sclerosis. PLoS One. 2015;10(5):e0127376. doi: 10.1371/journal.pone.0127376.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0127376</ArticleId><ArticleId IdType="pmc">PMC4446097</ArticleId><ArticleId IdType="pubmed">26016851</ArticleId></ArticleIdList></Reference><Reference><Citation>Prudencio M, Belzil VV, Batra R, Ross CA, Gendron TF, Pregent LJ, Murray ME, Overstreet KK, Piazza-Johnston AE, Desaro P, Bieniek KF, DeTure M, Lee WC, Biendarra SM, Davis MD, Baker MC, Perkerson RB, van Blitterswijk M, Stetler CT, Rademakers R, Link CD, Dickson DW, Boylan KB, Li H, Petrucelli L. Distinct brain transcriptome profiles in C9orf72-associated and sporadic ALS. Nat Neurosci. 2015;18(8):1175&#x2013;1182. doi: 10.1038/nn.4065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4065</ArticleId><ArticleId IdType="pmc">PMC4830686</ArticleId><ArticleId IdType="pubmed">26192745</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao F-B, Almeida S, Lopez-Gonzalez R. Dysregulated molecular pathways in amyotrophic lateral sclerosis-frontotemporal dementia spectrum disorder. EMBO J. 2017;36(20):2931&#x2013;2950. doi: 10.15252/embj.201797568.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201797568</ArticleId><ArticleId IdType="pmc">PMC5641681</ArticleId><ArticleId IdType="pubmed">28916614</ArticleId></ArticleIdList></Reference><Reference><Citation>Balendra R, Isaacs AM. C9orf72-mediated ALS and FTD: multiple pathways to disease. Nat Rev Neurol. 2018;14(9):544&#x2013;558. doi: 10.1038/s41582-018-0047-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-018-0047-2</ArticleId><ArticleId IdType="pmc">PMC6417666</ArticleId><ArticleId IdType="pubmed">30120348</ArticleId></ArticleIdList></Reference><Reference><Citation>Hautbergue GM, Castelli LM, Ferraiuolo L, Sanchez-Martinez A, Cooper-Knock J, Higginbottom A, Lin YH, Bauer CS, Dodd JE, Myszczynska MA, Alam SM, Garneret P, Chandran JS, Karyka E, Stopford MJ, Smith EF, Kirby J, Meyer K, Kaspar BK, Isaacs AM, el-Khamisy SF, de Vos KJ, Ning K, Azzouz M, Whitworth AJ, Shaw PJ. SRSF1-dependent nuclear export inhibition of C9ORF72 repeat transcripts prevents neurodegeneration and associated motor deficits. Nat Commun. 2017;8(1):16063. doi: 10.1038/ncomms16063.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms16063</ArticleId><ArticleId IdType="pmc">PMC5504286</ArticleId><ArticleId IdType="pubmed">28677678</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang YQ, Gattoni R, Stevenin J, Steitz JA. SR splicing factors serve as adapter proteins for TAP-dependent mRNA export. Mol Cell. 2003;11(3):837&#x2013;843. doi: 10.1016/S1097-2765(03)00089-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1097-2765(03)00089-3</ArticleId><ArticleId IdType="pubmed">12667464</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y, Yario TA, Steitz JA. A molecular link between SR protein dephosphorylation and mRNA export. Proc Natl Acad Sci U S A. 2004;101(26):9666&#x2013;9670. doi: 10.1073/pnas.0403533101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0403533101</ArticleId><ArticleId IdType="pmc">PMC470732</ArticleId><ArticleId IdType="pubmed">15210956</ArticleId></ArticleIdList></Reference><Reference><Citation>Tintaru AM, Hautbergue GM, Hounslow AM, Hung M-L, Lian L-Y, Craven CJ, Wilson SA. Structural and functional analysis of RNA and TAP binding to SF2/ASF. EMBO Rep. 2007;8(8):756&#x2013;762. doi: 10.1038/sj.embor.7401031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.embor.7401031</ArticleId><ArticleId IdType="pmc">PMC1978082</ArticleId><ArticleId IdType="pubmed">17668007</ArticleId></ArticleIdList></Reference><Reference><Citation>Hautbergue GM, Hung M-L, Golovanov AP, Lian L-Y, Wilson SA. Mutually exclusive interactions drive handover of mRNA from export adaptors to TAP. Proc Natl Acad Sci U S A. 2008;105(13):5154&#x2013;5159. doi: 10.1073/pnas.0709167105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0709167105</ArticleId><ArticleId IdType="pmc">PMC2278192</ArticleId><ArticleId IdType="pubmed">18364396</ArticleId></ArticleIdList></Reference><Reference><Citation>Hough LE, Dutta K, Sparks S, Temel DB, Kamal A, Tetenbaum-Novatt J, et al. The molecular mechanism of nuclear transport revealed by atomic-scale measurements. Elife. 2015;4. 10.7554/eLife.10027.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4621360</ArticleId><ArticleId IdType="pubmed">26371551</ArticleId></ArticleIdList></Reference><Reference><Citation>Milles S, Mercadante D, Aramburu IV, Jensen MR, Banterle N, Koehler C, Tyagi S, Clarke J, Shammas SL, Blackledge M, Gr&#xe4;ter F, Lemke EA. Plasticity of an ultrafast interaction between nucleoporins and nuclear transport receptors. Cell. 2015;163(3):734&#x2013;745. doi: 10.1016/j.cell.2015.09.047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2015.09.047</ArticleId><ArticleId IdType="pmc">PMC4622936</ArticleId><ArticleId IdType="pubmed">26456112</ArticleId></ArticleIdList></Reference><Reference><Citation>Walsh MJ, Hautbergue GM, Wilson SA. Structure and function of mRNA export adaptors. Biochem Soc Trans. 2010;38(1):232&#x2013;236. doi: 10.1042/BST0380232.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BST0380232</ArticleId><ArticleId IdType="pubmed">20074066</ArticleId></ArticleIdList></Reference><Reference><Citation>Heath CG, Viphakone N, Wilson SA. The role of TREX in gene expression and disease. Biochem J. 2016;473(19):2911&#x2013;2935. doi: 10.1042/BCJ20160010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BCJ20160010</ArticleId><ArticleId IdType="pmc">PMC5095910</ArticleId><ArticleId IdType="pubmed">27679854</ArticleId></ArticleIdList></Reference><Reference><Citation>Hautbergue GM. RNA nuclear export: from neurological disorders to Cancer. Adv Exp Med Biol. 2017;1007:89&#x2013;109. doi: 10.1007/978-3-319-60733-7_6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-319-60733-7_6</ArticleId><ArticleId IdType="pubmed">28840554</ArticleId></ArticleIdList></Reference><Reference><Citation>Castelli LM, Lin Y-H, Ferraiuolo L, Sanchez-Martinez A, Ning K, Azzouz M, et al. SRSF1-dependent nuclear export of C9ORF72 repeat-transcripts: targeting toxic gain-of-functions induced by protein sequestration. Ther Targets Neurol Dis. 2018;4:e1619.</Citation></Reference><Reference><Citation>Caceres JF, Krainer AR. Functional analysis of pre-mRNA splicing factor SF2/ASF structural domains. EMBO J. 1993;12(12):4715&#x2013;4726. doi: 10.1002/j.1460-2075.1993.tb06160.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/j.1460-2075.1993.tb06160.x</ArticleId><ArticleId IdType="pmc">PMC413916</ArticleId><ArticleId IdType="pubmed">8223480</ArticleId></ArticleIdList></Reference><Reference><Citation>Tacke R, Manley JL. Determinants of SR protein specificity. Curr Opin Cell Biol. 1999;11(3):358&#x2013;362. doi: 10.1016/S0955-0674(99)80050-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0955-0674(99)80050-7</ArticleId><ArticleId IdType="pubmed">10395560</ArticleId></ArticleIdList></Reference><Reference><Citation>Long JC, C&#xe1;ceres JF. The SR protein family of splicing factors: master regulators of gene expression. Biochem J. 2009;417(1):15&#x2013;27. doi: 10.1042/BJ20081501.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BJ20081501</ArticleId><ArticleId IdType="pubmed">19061484</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller-McNicoll M, Botti V, de Jesus Domingues AM, Brandl H, Schwich OD, Steiner MC, Curk T, Poser I, Zarnack K, Neugebauer KM. SR proteins are NXF1 adaptors that link alternative RNA processing to mRNA export. Genes Dev. 2016;30(5):553&#x2013;566. doi: 10.1101/gad.276477.115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.276477.115</ArticleId><ArticleId IdType="pmc">PMC4782049</ArticleId><ArticleId IdType="pubmed">26944680</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z, Krainer AR. Involvement of SR proteins in mRNA surveillance. Mol Cell. 2004;16(4):597&#x2013;607. doi: 10.1016/j.molcel.2004.10.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2004.10.031</ArticleId><ArticleId IdType="pubmed">15546619</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji X, Zhou Y, Pandit S, Huang J, Li H, Lin CY, Xiao R, Burge CB, Fu XD. SR proteins collaborate with 7SK and promoter-associated nascent RNA to release paused polymerase. Cell. 2013;153(4):855&#x2013;868. doi: 10.1016/j.cell.2013.04.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2013.04.028</ArticleId><ArticleId IdType="pmc">PMC4103662</ArticleId><ArticleId IdType="pubmed">23663783</ArticleId></ArticleIdList></Reference><Reference><Citation>Karni R, de Stanchina E, Lowe SW, Sinha R, Mu D, Krainer AR. The gene encoding the splicing factor SF2/ASF is a proto-oncogene. Nat Struct Mol Biol. 2007;14(3):185&#x2013;193. doi: 10.1038/nsmb1209.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsmb1209</ArticleId><ArticleId IdType="pmc">PMC4595851</ArticleId><ArticleId IdType="pubmed">17310252</ArticleId></ArticleIdList></Reference><Reference><Citation>Anczuk&#xf3;w O, Akerman M, Cl&#xe9;ry A, Wu J, Shen C, Shirole NH, Raimer A, Sun S, Jensen MA, Hua Y, Allain FHT, Krainer AR. SRSF1-regulated alternative splicing in breast Cancer. Mol Cell. 2015;60(1):105&#x2013;117. doi: 10.1016/j.molcel.2015.09.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2015.09.005</ArticleId><ArticleId IdType="pmc">PMC4597910</ArticleId><ArticleId IdType="pubmed">26431027</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu X, Yang D, Ding J-H, Wang W, Chu P-H, Dalton ND, Wang HY, Bermingham JR, Jr, Ye Z, Liu F, Rosenfeld MG, Manley JL, Ross J, Jr, Chen J, Xiao RP, Cheng H, Fu XD. ASF/SF2-regulated CaMKII&#x3b4; alternative splicing temporally reprograms excitation-contraction coupling in cardiac muscle. Cell. 2005;120(1):59&#x2013;72. doi: 10.1016/j.cell.2004.11.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2004.11.036</ArticleId><ArticleId IdType="pubmed">15652482</ArticleId></ArticleIdList></Reference><Reference><Citation>Desmarais JA, Unger C, Damjanov I, Meuth M, Andrews P. Apoptosis and failure of checkpoint kinase 1 activation in human induced pluripotent stem cells under replication stress. Stem Cell Res Ther. 2016;7(1):17. doi: 10.1186/s13287-016-0279-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13287-016-0279-2</ArticleId><ArticleId IdType="pmc">PMC4727355</ArticleId><ArticleId IdType="pubmed">26810087</ArticleId></ArticleIdList></Reference><Reference><Citation>Du Z-W, Chen H, Liu H, Lu J, Qian K, Huang C-L, et al. Generation and expansion of highly pure motor neuron progenitors from human pluripotent stem cells. Nat Commun. 2015;6(1):6626&#x2013;6629. doi: 10.1038/ncomms7626.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms7626</ArticleId><ArticleId IdType="pmc">PMC4375778</ArticleId><ArticleId IdType="pubmed">25806427</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizielinska S, Gronke S, Niccoli T, Ridler CE, Clayton EL, Devoy A, Moens T, Norona FE, Woollacott IOC, Pietrzyk J, Cleverley K, Nicoll AJ, Pickering-Brown S, Dols J, Cabecinha M, Hendrich O, Fratta P, Fisher EMC, Partridge L, Isaacs AM. C9orf72 repeat expansions cause neurodegeneration in Drosophila through arginine-rich proteins. Science. 2014;345(6201):1192&#x2013;1194. doi: 10.1126/science.1256800.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1256800</ArticleId><ArticleId IdType="pmc">PMC4944841</ArticleId><ArticleId IdType="pubmed">25103406</ArticleId></ArticleIdList></Reference><Reference><Citation>Aldrich R, Chandy KG, Grissmer S, Gutman GA, Kaczmarek LK, Wei AD, et al. Calcium- and sodium-activated potassium channels (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database. GtoPdb CITE. 2019;2019:1&#x2013;18. doi: 10.2218/gtopdb/F69/2019.4.</Citation><ArticleIdList><ArticleId IdType="doi">10.2218/gtopdb/F69/2019.4</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper-Knock J, Walsh MJ, Higginbottom A, Robin Highley J, Dickman MJ, Edbauer D, Ince PG, Wharton SB, Wilson SA, Kirby J, Hautbergue GM, Shaw PJ. Sequestration of multiple RNA recognition motif-containing proteins by C9orf72 repeat expansions. Brain. 2014;137(7):2040&#x2013;2051. doi: 10.1093/brain/awu120.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awu120</ArticleId><ArticleId IdType="pmc">PMC4065024</ArticleId><ArticleId IdType="pubmed">24866055</ArticleId></ArticleIdList></Reference><Reference><Citation>Greene JC, Whitworth AJ, Kuo I, Andrews LA, Feany MB, Pallanck LJ. Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants. Proc Natl Acad Sci U S A. 2003;100(7):4078&#x2013;4083. doi: 10.1073/pnas.0737556100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0737556100</ArticleId><ArticleId IdType="pmc">PMC153051</ArticleId><ArticleId IdType="pubmed">12642658</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, Batut P, Chaisson M, Gingeras TR. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29(1):15&#x2013;21. doi: 10.1093/bioinformatics/bts635.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/bts635</ArticleId><ArticleId IdType="pmc">PMC3530905</ArticleId><ArticleId IdType="pubmed">23104886</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng J, Kapranov P, Drenkow J, Dike S, Brubaker S, Patel S, Long J, Stern D, Tammana H, Helt G, Sementchenko V, Piccolboni A, Bekiranov S, Bailey DK, Ganesh M, Ghosh S, Bell I, Gerhard DS, Gingeras TR. Transcriptional maps of 10 human chromosomes at 5-nucleotide resolution. Science. 2005;308(5725):1149&#x2013;1154. doi: 10.1126/science.1108625.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1108625</ArticleId><ArticleId IdType="pubmed">15790807</ArticleId></ArticleIdList></Reference><Reference><Citation>Kapranov P, Cheng J, Dike S, Nix DA, Duttagupta R, Willingham AT, Stadler PF, Hertel J, Hackermuller J, Hofacker IL, Bell I, Cheung E, Drenkow J, Dumais E, Patel S, Helt G, Ganesh M, Ghosh S, Piccolboni A, Sementchenko V, Tammana H, Gingeras TR. RNA maps reveal new RNA classes and a possible function for pervasive transcription. Science. 2007;316(5830):1484&#x2013;1488. doi: 10.1126/science.1138341.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1138341</ArticleId><ArticleId IdType="pubmed">17510325</ArticleId></ArticleIdList></Reference><Reference><Citation>Li B, Dewey CN. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinformatics. 2011;12(1):323. doi: 10.1186/1471-2105-12-323.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2105-12-323</ArticleId><ArticleId IdType="pmc">PMC3163565</ArticleId><ArticleId IdType="pubmed">21816040</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2009;26:139&#x2013;140. doi: 10.1093/bioinformatics/btp616.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btp616</ArticleId><ArticleId IdType="pmc">PMC2796818</ArticleId><ArticleId IdType="pubmed">19910308</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasprzyk A. BioMart: driving a paradigm change in biological data management. Database. 2011;2011:bar049. 10.1093/database/bar049.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3215098</ArticleId><ArticleId IdType="pubmed">22083790</ArticleId></ArticleIdList></Reference><Reference><Citation>Anders S, Reyes A, Huber W. Detecting differential usage of exons from RNA-seq data. Genome Res. 2012;22(10):2008&#x2013;2017. doi: 10.1101/gr.133744.111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gr.133744.111</ArticleId><ArticleId IdType="pmc">PMC3460195</ArticleId><ArticleId IdType="pubmed">22722343</ArticleId></ArticleIdList></Reference><Reference><Citation>McKenzie AT, Wang M, Hauberg ME, Fullard JF, Kozlenkov A, Keenan A, et al. Brain cell type specific gene expression and co-expression network architectures. Sci Rep. 2018;8(1):8868. doi: 10.1038/s41598-018-27293-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-27293-5</ArticleId><ArticleId IdType="pmc">PMC5995803</ArticleId><ArticleId IdType="pubmed">29892006</ArticleId></ArticleIdList></Reference><Reference><Citation>Cahoy JD, Emery B, Kaushal A, Foo LC, Zamanian JL, Christopherson KS, Xing Y, Lubischer JL, Krieg PA, Krupenko SA, Thompson WJ, Barres BA. A transcriptome database for astrocytes, neurons, and oligodendrocytes: a new resource for understanding brain development and function. J Neurosci. 2008;28(1):264&#x2013;278. doi: 10.1523/JNEUROSCI.4178-07.2008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.4178-07.2008</ArticleId><ArticleId IdType="pmc">PMC6671143</ArticleId><ArticleId IdType="pubmed">18171944</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang DW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4(1):44&#x2013;57. doi: 10.1038/nprot.2008.211.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2008.211</ArticleId><ArticleId IdType="pubmed">19131956</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang DW, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 2009;37(1):1&#x2013;13. doi: 10.1093/nar/gkn923.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkn923</ArticleId><ArticleId IdType="pmc">PMC2615629</ArticleId><ArticleId IdType="pubmed">19033363</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitfield ML, George LK, Grant GD, Perou CM. Common markers of proliferation. Nat Rev Cancer. 2006;6(2):99&#x2013;106. doi: 10.1038/nrc1802.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrc1802</ArticleId><ArticleId IdType="pubmed">16491069</ArticleId></ArticleIdList></Reference><Reference><Citation>Waldman YY, Geiger T, Ruppin E. A genome-wide systematic analysis reveals different and predictive proliferation expression signatures of cancerous vs non-cancerous cells. PLoS Genet. 2013;9:e1003806. doi: 10.1371/journal.pgen.1003806.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1003806</ArticleId><ArticleId IdType="pmc">PMC3778010</ArticleId><ArticleId IdType="pubmed">24068970</ArticleId></ArticleIdList></Reference><Reference><Citation>Han S, Miller JE, Byun S, Kim D, Risacher SL, Saykin AJ, et al. Identification of exon skipping events associated with Alzheimer&#x2019;s disease in the human hippocampus. BMC Med Genet. 2019;12(S1):13. doi: 10.1186/s12920-018-0453-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12920-018-0453-8</ArticleId><ArticleId IdType="pmc">PMC6357347</ArticleId><ArticleId IdType="pubmed">30704480</ArticleId></ArticleIdList></Reference><Reference><Citation>Bj&#xf8;rklund SS, Panda A, Kumar S, Seiler M, Robinson D, Gheeya J, Yao M, Aln&#xe6;s GIG, Toppmeyer D, Riis M, Naume B, B&#xf8;rresen-Dale AL, Kristensen VN, Ganesan S, Bhanot G. Widespread alternative exon usage in clinically distinct subtypes of invasive ductal carcinoma. Sci Rep. 2017;7(1):5568. doi: 10.1038/s41598-017-05537-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-05537-0</ArticleId><ArticleId IdType="pmc">PMC5514065</ArticleId><ArticleId IdType="pubmed">28717182</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng H, Li T, Zhang X. Characterization of kinase gene expression and splicing profile in prostate cancer with RNA-Seq data. BMC Genomics. 2018;19(S6):564. doi: 10.1186/s12864-018-4925-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12864-018-4925-1</ArticleId><ArticleId IdType="pmc">PMC6101066</ArticleId><ArticleId IdType="pubmed">30367578</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwon I, Xiang S, Kato M, Wu L, Theodoropoulos P, Wang T, Kim J, Yun J, Xie Y, McKnight SL. Poly-dipeptides encoded by the C9orf72 repeats bind nucleoli, impede RNA biogenesis, and kill cells. Science. 2014;345(6201):1139&#x2013;1145. doi: 10.1126/science.1254917.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1254917</ArticleId><ArticleId IdType="pmc">PMC4459787</ArticleId><ArticleId IdType="pubmed">25081482</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin S, Lopez-Gonzalez R, Kunz RC, Gangopadhyay J, Borufka C, Gygi SP, Gao FB, Reed R. Evidence that C9ORF72 dipeptide repeat proteins associate with U2 snRNP to cause Mis-splicing in ALS/FTD patients. Cell Rep. 2017;19(11):2244&#x2013;2256. doi: 10.1016/j.celrep.2017.05.056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2017.05.056</ArticleId><ArticleId IdType="pmc">PMC5653973</ArticleId><ArticleId IdType="pubmed">28614712</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi KY, Mori E, Nizami ZF, Lin Y, Kato M, Xiang S, Wu LC, Ding M, Yu Y, Gall JG, McKnight SL. Toxic PRn poly-dipeptides encoded by the C9orf72 repeat expansion block nuclear import and export. Proc Natl Acad Sci U S A. 2017;114(7):E1111&#x2013;E1117. doi: 10.1073/pnas.1620293114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1620293114</ArticleId><ArticleId IdType="pmc">PMC5320981</ArticleId><ArticleId IdType="pubmed">28069952</ArticleId></ArticleIdList></Reference><Reference><Citation>White MR, Mitrea DM, Zhang P, Stanley CB, Cassidy DE, Nourse A, Phillips AH, Tolbert M, Taylor JP, Kriwacki RW. C9orf72 poly(PR) dipeptide repeats disturb biomolecular phase separation and disrupt nucleolar function. Mol Cell. 2019;74(4):713&#x2013;716. doi: 10.1016/j.molcel.2019.03.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2019.03.019</ArticleId><ArticleId IdType="pmc">PMC6525025</ArticleId><ArticleId IdType="pubmed">30981631</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanneste J, Vercruysse T, Boeynaems S, Sicart A, Van Damme P, Daelemans D, et al. C9orf72-generated poly-GR and poly-PR do not directly interfere with nucleocytoplasmic transport. Sci Rep. 2019;9(1):15728&#x2013;15710. doi: 10.1038/s41598-019-52035-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-52035-6</ArticleId><ArticleId IdType="pmc">PMC6823349</ArticleId><ArticleId IdType="pubmed">31673013</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayes LR, Duan L, Bowen K, Kalab P, Rothstein JD. C9orf72 arginine-rich dipeptide repeat proteins disrupt karyopherin-mediated nuclear import. Elife. 2020;9. 10.7554/eLife.51685.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7051184</ArticleId><ArticleId IdType="pubmed">32119645</ArticleId></ArticleIdList></Reference><Reference><Citation>Wainger BJ, Kiskinis E, Mellin C, Wiskow O, Han SSW, Sandoe J, Perez NP, Williams LA, Lee S, Boulting G, Berry JD, Brown RH, Jr, Cudkowicz ME, Bean BP, Eggan K, Woolf CJ. Intrinsic membrane hyperexcitability of amyotrophic lateral sclerosis patient-derived motor neurons. Cell Rep. 2014;7(1):1&#x2013;11. doi: 10.1016/j.celrep.2014.03.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2014.03.019</ArticleId><ArticleId IdType="pmc">PMC4023477</ArticleId><ArticleId IdType="pubmed">24703839</ArticleId></ArticleIdList></Reference><Reference><Citation>Devlin A-C, Burr K, Borooah S, Foster JD, Cleary EM, Geti I, Vallier L, Shaw CE, Chandran S, Miles GB. Human iPSC-derived motoneurons harbouring TARDBP or C9ORF72 ALS mutations are dysfunctional despite maintaining viability. Nat Commun. 2015;6(1):5999&#x2013;5912. doi: 10.1038/ncomms6999.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms6999</ArticleId><ArticleId IdType="pmc">PMC4338554</ArticleId><ArticleId IdType="pubmed">25580746</ArticleId></ArticleIdList></Reference><Reference><Citation>Westergard T, McAvoy K, Russell K, Wen X, Pang Y, Morris B, et al. Repeat-associated non-AUG translation in C9orf72-ALS/FTD is driven by neuronal excitation and stress. EMBO Mol Med. 2019;11:1&#x2013;14. doi: 10.15252/emmm.201809423.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.201809423</ArticleId><ArticleId IdType="pmc">PMC6365928</ArticleId><ArticleId IdType="pubmed">30617154</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao C, Devlin A-C, Chouhan AK, Selvaraj BT, Stavrou M, Burr K, Brivio V, He X, Mehta AR, Story D, Shaw CE, Dando O, Hardingham GE, Miles GB, Chandran S. Mutant C9orf72 human iPSC-derived astrocytes cause non-cell autonomous motor neuron pathophysiology. Glia. 2020;68(5):1046&#x2013;1064. doi: 10.1002/glia.23761.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.23761</ArticleId><ArticleId IdType="pmc">PMC7078830</ArticleId><ArticleId IdType="pubmed">31841614</ArticleId></ArticleIdList></Reference><Reference><Citation>Sareen D, O'Rourke JG, Meera P, Muhammad AKMG, Grant S, Simpkinson M, et al. Targeting RNA foci in iPSC-derived motor neurons from ALS patients with a C9ORF72 repeat expansion. Sci Transl Med. 2013;5:208ra149. doi: 10.1126/scitranslmed.3007529.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.3007529</ArticleId><ArticleId IdType="pmc">PMC4090945</ArticleId><ArticleId IdType="pubmed">24154603</ArticleId></ArticleIdList></Reference><Reference><Citation>Satoh J-I, Yamamoto Y, Kitano S, Takitani M, Asahina N, Kino Y. Molecular network analysis suggests a logical hypothesis for the pathological role of C9orf72 in amyotrophic lateral sclerosis/frontotemporal dementia. J Cent Nerv Syst Dis. 2014;6:69&#x2013;78. doi: 10.4137/JCNSD.S18103.</Citation><ArticleIdList><ArticleId IdType="doi">10.4137/JCNSD.S18103</ArticleId><ArticleId IdType="pmc">PMC4149381</ArticleId><ArticleId IdType="pubmed">25210488</ArticleId></ArticleIdList></Reference><Reference><Citation>Conlon EG, Fagegaltier D, Agius P, Davis-Porada J, Gregory J, Hubbard I, et al. Unexpected similarities between C9ORF72 and sporadic forms of ALS/FTD suggest a common disease mechanism. Elife. 2018;7:959. doi: 10.7554/eLife.37754.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.37754</ArticleId><ArticleId IdType="pmc">PMC6103746</ArticleId><ArticleId IdType="pubmed">30003873</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones AR, Troakes C, King A, Sahni V, De Jong S, Bossers K, et al. Stratified gene expression analysis identifies major amyotrophic lateral sclerosis genes. Neurobiol Aging. 2015;36:2006.e1&#x2013;2006.e9. doi: 10.1016/j.neurobiolaging.2015.02.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2015.02.017</ArticleId><ArticleId IdType="pubmed">25801576</ArticleId></ArticleIdList></Reference><Reference><Citation>Str&#xe4;sser K, Masuda S, Mason P, Pfannstiel J, Oppizzi M, Rodriguez-Navarro S, et al. TREX is a conserved complex coupling transcription with messenger RNA export. Nature. 2002;417(6886):304&#x2013;308. doi: 10.1038/nature746.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature746</ArticleId><ArticleId IdType="pubmed">11979277</ArticleId></ArticleIdList></Reference><Reference><Citation>Masuda S, Das R, Cheng H, Hurt E, Dorman N, Reed R. Recruitment of the human TREX complex to mRNA during splicing. Genes Dev. 2005;19(13):1512&#x2013;1517. doi: 10.1101/gad.1302205.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.1302205</ArticleId><ArticleId IdType="pmc">PMC1172058</ArticleId><ArticleId IdType="pubmed">15998806</ArticleId></ArticleIdList></Reference><Reference><Citation>Viphakone N, Sudbery I, Griffith L, Heath CG, Sims D, Wilson SA. Co-transcriptional loading of RNA export factors shapes the human transcriptome. Mol Cell. 2019;75(2):310&#x2013;318. doi: 10.1016/j.molcel.2019.04.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2019.04.034</ArticleId><ArticleId IdType="pmc">PMC6675937</ArticleId><ArticleId IdType="pubmed">31104896</ArticleId></ArticleIdList></Reference><Reference><Citation>Dufu K, Livingstone MJ, Seebacher J, Gygi SP, Wilson SA, Reed R. ATP is required for interactions between UAP56 and two conserved mRNA export proteins, Aly and CIP29, to assemble the TREX complex. Genes Dev. 2010;24(18):2043&#x2013;2053. doi: 10.1101/gad.1898610.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.1898610</ArticleId><ArticleId IdType="pmc">PMC2939366</ArticleId><ArticleId IdType="pubmed">20844015</ArticleId></ArticleIdList></Reference><Reference><Citation>Viphakone N, Hautbergue GM, Walsh M, Chang C-T, Holland A, Folco EG, Reed R, Wilson SA. TREX exposes the RNA-binding domain of Nxf1 to enable mRNA export. Nat Commun. 2012;3(1):1006. doi: 10.1038/ncomms2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms2005</ArticleId><ArticleId IdType="pmc">PMC3654228</ArticleId><ArticleId IdType="pubmed">22893130</ArticleId></ArticleIdList></Reference><Reference><Citation>Hao Z, Liu L, Tao Z, Wang R, Ren H, Sun H, Lin Z, Zhang Z, Mu C, Zhou J, Wang G. Motor dysfunction and neurodegeneration in a C9orf72 mouse line expressing poly-PR. Nat Commun. 2019;10(1):2906&#x2013;2911. doi: 10.1038/s41467-019-10956-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-10956-w</ArticleId><ArticleId IdType="pmc">PMC6606620</ArticleId><ArticleId IdType="pubmed">31266945</ArticleId></ArticleIdList></Reference><Reference><Citation>Freibaum BD, Lu Y, Lopez-Gonzalez R, Kim NC, Almeida S, Lee K-H, Badders N, Valentine M, Miller BL, Wong PC, Petrucelli L, Kim HJ, Gao FB, Taylor JP. GGGGCC repeat expansion in C9orf72 compromises nucleocytoplasmic transport. Nature. 2015;525(7567):129&#x2013;133. doi: 10.1038/nature14974.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature14974</ArticleId><ArticleId IdType="pmc">PMC4631399</ArticleId><ArticleId IdType="pubmed">26308899</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Y-B, Chen H-J, Peres JN, Gomez-Deza J, Attig J, &#x160;talekar M, Troakes C, Nishimura AL, Scotter EL, Vance C, Adachi Y, Sardone V, Miller JW, Smith BN, Gallo JM, Ule J, Hirth F, Rogelj B, Houart C, Shaw CE. Hexanucleotide repeats in ALS/FTD form length-dependent RNA foci, sequester RNA binding proteins, and are neurotoxic. Cell Rep. 2013;5(5):1178&#x2013;1186. doi: 10.1016/j.celrep.2013.10.049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2013.10.049</ArticleId><ArticleId IdType="pmc">PMC3898469</ArticleId><ArticleId IdType="pubmed">24290757</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a-Berrocoso T, Llombart V, Col&#xe0;s-Camp&#xe0;s L, Hainard A, Licker V, Penalba A, Ramiro L, Simats A, Bustamante A, Mart&#xed;nez-Saez E, Canals F, Sanchez JC, Montaner J. Single cell Immuno-laser microdissection coupled to label-free proteomics to reveal the Proteotypes of human brain cells after ischemia. Mol Cell Proteomics. 2018;17(1):175&#x2013;189. doi: 10.1074/mcp.RA117.000419.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/mcp.RA117.000419</ArticleId><ArticleId IdType="pmc">PMC5750846</ArticleId><ArticleId IdType="pubmed">29133510</ArticleId></ArticleIdList></Reference><Reference><Citation>Lemaire R, Prasad J, Kashima T, Gustafson J, Manley JL, Lafyatis R. Stability of a PKCI-1-related mRNA is controlled by the splicing factor ASF/SF2: a novel function for SR proteins. Genes Dev. 2002;16(5):594&#x2013;607. doi: 10.1101/gad.939502.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.939502</ArticleId><ArticleId IdType="pmc">PMC155348</ArticleId><ArticleId IdType="pubmed">11877379</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun S, Zhang Z, Sinha R, Karni R, Krainer AR. SF2/ASF autoregulation involves multiple layers of post-transcriptional and translational control. Nat Struct Mol Biol. 2010;17(3):306&#x2013;312. doi: 10.1038/nsmb.1750.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsmb.1750</ArticleId><ArticleId IdType="pmc">PMC2921916</ArticleId><ArticleId IdType="pubmed">20139984</ArticleId></ArticleIdList></Reference><Reference><Citation>Delestienne N, Wauquier C, Soin R, Dierick J-F, Gueydan C, Kruys V. The splicing factor ASF/SF2 is associated with TIA-1-related/TIA-1-containing ribonucleoproteic complexes and contributes to post-transcriptional repression of gene expression. FEBS J. 2010;277(11):2496&#x2013;2514. doi: 10.1111/j.1742-4658.2010.07664.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1742-4658.2010.07664.x</ArticleId><ArticleId IdType="pubmed">20477871</ArticleId></ArticleIdList></Reference><Reference><Citation>Kulkarni M, Ozgur S, Stoecklin G. On track with P-bodies. Biochem Soc Trans. 2010;38(1):242&#x2013;251. doi: 10.1042/BST0380242.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BST0380242</ArticleId><ArticleId IdType="pubmed">20074068</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanford JR, Gray NK, Beckmann K, C&#xe1;ceres JF. A novel role for shuttling SR proteins in mRNA translation. Genes Dev. 2004;18(7):755&#x2013;768. doi: 10.1101/gad.286404.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.286404</ArticleId><ArticleId IdType="pmc">PMC387416</ArticleId><ArticleId IdType="pubmed">15082528</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanford JR, Ellis JD, Cazalla D, C&#xe1;ceres JF. Reversible phosphorylation differentially affects nuclear and cytoplasmic functions of splicing factor 2/alternative splicing factor. Proc Natl Acad Sci U S A. 2005;102(42):15042&#x2013;15047. doi: 10.1073/pnas.0507827102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0507827102</ArticleId><ArticleId IdType="pmc">PMC1257746</ArticleId><ArticleId IdType="pubmed">16210245</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>